Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond

The systemic treatment landscape for advanced hepatocellular carcinoma (HCC) has experienced tremendous paradigm shift towards targeting tumor microenvironment (TME) following recent trials utilizing immune checkpoint blockade (ICB). However, limited success of ICB as monotherapy mandates the evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun Hua, Tai, David, Yip, Connie, Choo, Su Pin, Chew, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561368/
https://www.ncbi.nlm.nih.gov/pubmed/33117354
http://dx.doi.org/10.3389/fimmu.2020.568759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561368/
https://www.ncbi.nlm.nih.gov/pubmed/33117354
http://dx.doi.org/10.3389/fimmu.2020.568759

Ejemplares similares